SEARCH

SEARCH BY CITATION

Keywords:

  • Branchio-oto syndrome;
  • enlargement of vestibular aqueduct;
  • SIX1;
  • EYA1;
  • SLC26A4

Abstract

Objectives: The objectives of this study were to identify SIX1 gene mutations in a patient with branchio-oto syndrome (BO) and to clarify the relationship between SIX1 mutation and enlargement of the vestibular aqueduct (EVA).

Methods: A genetic study and retrospective chart review for a patient in whom EYA1 mutation had already been excluded was conducted. We studied a Japanese patient who had autosomal-dominant mixed hearing loss, a unilateral ear pit and unilateral EVA, and who was previously diagnosed as having BO. We searched for SIX1 and SLC26A4 mutations using polymerase chain reaction and direct gene sequencing.

Results: The patient carried a heterozygous A[RIGHTWARDS ARROW]G mutation at nucleotide 386 within exon 1 of SIX1 that resulted in substitution of a cysteine for a tyrosine at codon 129 (Y129C) of the gene product. Y129C is a previously identified SIX1 mutation and was not detected in any of our 164 control chromosomes. No SLC26A4 mutations were identified.

Conclusion: Y129C mutation in SIX1 may cause EVA as well as BO.